Geron (NASDAQ:GERN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 66.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $51.771 million which beat the analyst consensus estimate of $50.582 million by 2.35 percent. This is a 30.72 percent increase over sales of $39.603 million the same period last year.